Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
S Methylprednisolone Aspergillus fumigatus infection and pulmonary aspergillosis leading to constrictive Aspergillus pericarditis: case reportA 3-year-old girl developed Aspergillus fumigatus infection and pulmonary aspergillosis leading to constrictive Aspergillus pericarditis following treatment with methylprednisolone for autoimmune-mediated gastric outlet obstruction.The girl, who was diagnosed with homozygous X-linked chronic granulomatous disease, had been receiving treatment with interferon γ-1b. She was admitted to the emergency service with shortness of breath and fever. Her medical history was significant for autoimmune-mediated gastric outlet obstruction, for which she had been receiving treatment with oral methylprednisolone 20mg daily; however, 1 month prior to the current admission, her methylprednisolone had been stopped. On admission, physical examination showed fever, tachypnoea, tachycardia, narrow pulse pressure and tender hepatomegaly and distended neck veins. She was in New York Heart Association (NYHA) class II-III. Additionally, peripheral oxygen saturation was found to be 87% in ambient air. A chest X-ray showed bilateral pneumonic infiltrations. Laboratory findings revealed anaemia, leucocytosis and elevated CRP level. Polymerase chain reaction was positive for coronavirus of an unknown aetiology. Serological assay of galactomannan was positive. Contrast-enhanced chest CT showed bilateral diffuse lung infiltrates along with alveolar condensation. Additionally, pericardial thickening with abscess formations at the diaphragmatic surface of the heart and around the right atrium was observed. Constrictive Aspergillus pericarditis was considered. Subsequently, a diagnosis of congestive heart failure and pneumonia was made, and she was admitted to the hospital.The girl was treated with empirical wide-spectrum antibiotherapy with linezolid, meropenem, cotrimoxazole [trimethoprim/ sulfamethoxazole], ganciclovir [Cymevene] and caspofungin in addition to an anti-congestive regimen. Trans-thoracic echocardiography demonstrated no pericardial effusion; however, hyperechogenic formations at the apex and undersurface of the heart with approximately 4-6mm of pericardial thickening were observed. Left ventricular ejection fraction was found to be 65%. Additionally, tethering of the right ventricular free wall with interventricular septal bouncing was noted. A pulsed-wave doppler recording through the apical window at the tricuspid level showed inspiratory decrease and expiratory increase in early inflow velocity along with E/A >1. Therefore, diastolic dysfunction was considered. During the hospitalisation stay, her interferon-γ-1b therapy was continued, and she intermittently received granulocyte colony stimulating factors. Subsequently, she underwent a sternotomy and the pericardium was dissected free from one phrenic nerve to the other until the right ventricle was completely clear and the left ventricle was partially liberated. Additionally, several islands of thick, loculated, firm-walled, fibrinous...
S Methylprednisolone Aspergillus fumigatus infection and pulmonary aspergillosis leading to constrictive Aspergillus pericarditis: case reportA 3-year-old girl developed Aspergillus fumigatus infection and pulmonary aspergillosis leading to constrictive Aspergillus pericarditis following treatment with methylprednisolone for autoimmune-mediated gastric outlet obstruction.The girl, who was diagnosed with homozygous X-linked chronic granulomatous disease, had been receiving treatment with interferon γ-1b. She was admitted to the emergency service with shortness of breath and fever. Her medical history was significant for autoimmune-mediated gastric outlet obstruction, for which she had been receiving treatment with oral methylprednisolone 20mg daily; however, 1 month prior to the current admission, her methylprednisolone had been stopped. On admission, physical examination showed fever, tachypnoea, tachycardia, narrow pulse pressure and tender hepatomegaly and distended neck veins. She was in New York Heart Association (NYHA) class II-III. Additionally, peripheral oxygen saturation was found to be 87% in ambient air. A chest X-ray showed bilateral pneumonic infiltrations. Laboratory findings revealed anaemia, leucocytosis and elevated CRP level. Polymerase chain reaction was positive for coronavirus of an unknown aetiology. Serological assay of galactomannan was positive. Contrast-enhanced chest CT showed bilateral diffuse lung infiltrates along with alveolar condensation. Additionally, pericardial thickening with abscess formations at the diaphragmatic surface of the heart and around the right atrium was observed. Constrictive Aspergillus pericarditis was considered. Subsequently, a diagnosis of congestive heart failure and pneumonia was made, and she was admitted to the hospital.The girl was treated with empirical wide-spectrum antibiotherapy with linezolid, meropenem, cotrimoxazole [trimethoprim/ sulfamethoxazole], ganciclovir [Cymevene] and caspofungin in addition to an anti-congestive regimen. Trans-thoracic echocardiography demonstrated no pericardial effusion; however, hyperechogenic formations at the apex and undersurface of the heart with approximately 4-6mm of pericardial thickening were observed. Left ventricular ejection fraction was found to be 65%. Additionally, tethering of the right ventricular free wall with interventricular septal bouncing was noted. A pulsed-wave doppler recording through the apical window at the tricuspid level showed inspiratory decrease and expiratory increase in early inflow velocity along with E/A >1. Therefore, diastolic dysfunction was considered. During the hospitalisation stay, her interferon-γ-1b therapy was continued, and she intermittently received granulocyte colony stimulating factors. Subsequently, she underwent a sternotomy and the pericardium was dissected free from one phrenic nerve to the other until the right ventricle was completely clear and the left ventricle was partially liberated. Additionally, several islands of thick, loculated, firm-walled, fibrinous...
Campylobacter spp. is a gram-negative bacillus that causes infectious enteritis and consists of several species, including Campylobacter jejuni, Campylobacter coli, and Campylobacter fetus. Although C. jejuni and C. coli cause infectious enteritis primarily in immunocompetent hosts, C. fetus causes extraintestinal infections such as septicemia, meningitis, and perinatal infections in immunocompromised hosts, as well as myopericarditis in rare cases. Only a few cases of infectious myo(peri)carditis associated with C. coli in immunocompetent hosts have been reported. These studies concentrated on antecedent C. coli enterocolitis and never demonstrated a positive culture in the pericardial fluid.A 72-year-old Japanese man presented with a 2-week fever, cough, and vomiting lasting. He was on hemodialysis for polycystic kidney disease, as well as medication for diabetes and hypertension. A chest computed tomography (CT) scan and a transthoracic echocardiogram revealed bilateral pleural fluid and large pericardial fluid at the time of admission. C. coli was identified from blood culture samples and blood-tinged pericardial fluid. He was successfully treated with antibacterial chemotherapy as well as pericardial fluid drainage and was discharged from the hospital with no complications.In this case, the presence of C. coli in the pericardial fluid confirmed the diagnosis of C. coli pericarditis. C. coli may cause septic pericarditis in immunocompromised hosts, despite typically causing only enteritis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.